Aerie Pharmaceuticals Inc

BANK OF AMERICA CORP /DE/

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

1,081,133

Value ($000)

16,358

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	16,358	0.0%	1,081,133	9/30/2022
2022 Q2	8/12/2022	19,497	0.0%	2,599,748	6/30/2022
2022 Q1	5/16/2022	25,212	0.0%	2,770,652	3/31/2022
2021 Q4	2/8/2022	16,524	0.0%	2,353,893	12/31/2021
2021 Q3	11/15/2021	29,961	0.0%	2,628,097	9/30/2021
2021 Q2	9/13/2021	42,040	0.0%	2,625,907	6/30/2021
2021 Q1	5/14/2021	47,536	0.0%	2,660,101	3/31/2021
2020 Q4	2/10/2021	40,526	0.0%	2,999,726	12/31/2020
2020 Q3	11/13/2020	31,539	0.0%	2,679,710	9/30/2020
2020 Q2	8/14/2020	32,830	0.0%	2,224,290	6/30/2020
2020 Q1	5/15/2020	19,953	0.0%	1,477,980	3/31/2020
2019 Q4	2/14/2020	28,035	0.0%	1,159,914	12/31/2019
2014 Q1	5/15/2014	1	0.0%	37	3/31/2014
2013 Q4	2/18/2014	2	0.0%	100	12/31/2013